Literature DB >> 3191360

Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer.

B J Jenkins1, M J Caulfield, C G Fowler, D F Badenoch, R C Tiptaft, A M Paris, H F Hope-Stone, R T Oliver, J P Blandy.   

Abstract

One hundred and eighty-two patients with invasive (T2/T3) bladder cancer were treated by radical radiotherapy at the London Hospital between 1974 and December 1985. Cystectomy was reserved for patients whose tumours either did not respond completely to radiation or recurred later, provided they were fit for surgery and had not developed distant metastases. The overall corrected 5-year survival rate was 40%; 75 patients responded to radiation and did not relapse during the period of follow-up; 20 patients had an initial response to radiation but subsequently relapsed, with a 5-year survival rate following relapse of 20%. Of these, 11 patients had a cystectomy with a 5-year survival following relapse of 36%, whereas all 9 patients who did not have a cystectomy died within 3 years; 87 patients who did not respond to radiation had a 5-year survival rate of 18%. Of these, 22 patients underwent salvage cystectomy with a 5-year survival of 47%, whereas the 65 patients who did not have a cystectomy had a 5-year survival of 3%. These results justify a policy of radical radiotherapy and salvage cystectomy rather than elective cystectomy in the treatment of invasive bladder cancer.

Entities:  

Mesh:

Year:  1988        PMID: 3191360     DOI: 10.1111/j.1464-410x.1988.tb04362.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  17 in total

1.  Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder.

Authors:  J E Martin; B J Jenkins; R J Zuk; J P Blandy; S I Baithun
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

2.  Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.

Authors:  Arjun Balar; Dean F Bajorin; Matthew I Milowsky
Journal:  Ther Adv Urol       Date:  2011-06

Review 3.  Bladder cancer: a review of diagnosis and management.

Authors:  M C Metts; J C Metts; S J Milito; C R Thomas
Journal:  J Natl Med Assoc       Date:  2000-06       Impact factor: 1.798

Review 4.  Therapeutic interventions targeting organ preservation in muscle-invasive bladder cancer: a review.

Authors:  Georgios Koukourakis; Vassilios Kouloulias; Georgios Zacharias; Anastasia Sotiropoulou-Lontou; Michael Koukourakis
Journal:  Clin Transl Oncol       Date:  2011-05       Impact factor: 3.405

Review 5.  Bladder-sparing approaches to invasive disease.

Authors:  Jason A Efstathiou; Anthony L Zietman; Donald S Kaufman; Niall M Heney; John J Coen; William U Shipley
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

6.  Effective bladder preservation strategy with low-dose radiation therapy and concurrent intraarterial chemotherapy for muscle-invasive bladder cancer.

Authors:  Hitoshi Ikushima; Seiji Iwamoto; Kyohsuke Osaki; Shunsuke Furutani; Kyoh Yamashita; Takashi Kawanaka; Akiko Kubo; Yoshihiro Takegawa; Takaharu Kudoh; Hiroomi Kanayama; Hiromu Nishitani
Journal:  Radiat Med       Date:  2008-04

7.  Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.

Authors:  Celestia S Higano; Catherine M Tangen; Wael A Sakr; James Faulkner; Saul E Rivkin; Frederick J Meyers; Maha Hussain; Laurence H Baker; Kenneth J Russell; E David Crawford
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

8.  Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder.

Authors:  J E Martin; B J Jenkins; R J Zuk; R T Oliver; S I Baithun
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 9.  Landmarks in the treatment of muscle-invasive bladder cancer.

Authors:  Niyati Lobo; Chloe Mount; Kawa Omar; Rajesh Nair; Ramesh Thurairaja; Muhammad Shamim Khan
Journal:  Nat Rev Urol       Date:  2017-07-04       Impact factor: 14.432

10.  Conservative treatment of invasive bladder cancer.

Authors:  N J Rene; F B Cury; L Souhami
Journal:  Curr Oncol       Date:  2009-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.